This Journal has an Open Access Option
 |
Including DNA, RNA,
and Cell Therapies
|
Promising Results of Gene Therapy to Treat Diseases of the Eye Described in Human Gene Therapy
Human Gene Therapy provides “Instant Online” publication 72 hours after acceptance
...and the Official Journal of
Due to the dynamic nature of this field, the journal has a rapid online publication policy. All articles are published online within 3-4 weeks of acceptance, and will appear at a later date in the print journal.
Human Gene Therapy is the definitive peer-reviewed rapid-publication journal covering all aspects of human gene therapy. The Journal publishes scientific papers on original investigations into the transfer and expression of genes in mammals, including humans. Improvements in vector development, delivery systems, and animal models, particularly in the areas of cancer, heart disease, viral disease, genetic disease, and neurological disease, are covered.
Other key features include a continuously updated directory of human gene marker and gene therapy clinical protocols, as well as ethical/legal/regulatory papers related directly to the area of gene transfer into humans.
Latest Impact Factor* is 4.202
* 2009 Journal Citation Reports® published by Thomson Reuters, 2010.
Indexed/Abstracted in:
MEDLINE; Current Contents®/Life Sciences; EMBASE/Excerpta Medica; Science Citation Index Expanded; Science Citation Index®; BIOSIS Previews; Biotechnology Citation Index®; Biological Abstracts; EMBiology; Scopus